针对精神病性障碍患者创伤后应激的创伤聚焦疗法:RE.PROCESS随机对照试验研究方案
RE.PROCESS是首个在同一情境下比较认知重构、延长暴露和眼动脱敏与再加工三种创伤聚焦疗法与等待名单对照的 Pragmatic 单盲多中心优效性随机对照试验方案。纳入200例符合DSM-5 PTSD诊断且CAPS-5总分≥23的精神分裂症谱系精神病性障碍患者,随机分配至16次TFT或WL,均接受精神病常规治疗,主要比较基线至6个月随访PTSD症状严重度变化。
要点
- RE.PROCESS首次在同一情境下直接比较CR、PE和EMDR与TAU对精神病性障碍共病PTSD患者的效果。
- 纳入标准为年龄≥16岁、CAPS-5符合DSM-5 PTSD诊断且总分≥23、SCID-5确认精神分裂症谱系精神病性障碍。
- 200例参与者随机接受16次CR、PE或EMDR或等待名单,均联合精神病常规治疗。
核心结论
- RE.PROCESS将是首个在同一情境下比较CR、PE和EMDR与等待名单对照对精神病性障碍患者PTSD症状影响的随机对照试验。
- 次要目标包括评估对临床与功能结局的短期和长期效果。
研究设计与样本
- Pragmatic、单盲、多中心、优效性随机对照试验方案,在自然主义治疗环境中比较CR、PE、EMDR与等待名单对照。
- 计划纳入200例参与者,随机分配至16次TFT或WL,均联合精神病常规治疗。
- 纳入标准:年龄≥16岁;CAPS-5符合DSM-5 PTSD全部诊断标准且总分≥23;SCID-5确认精神分裂症谱系精神病性障碍。
主要发现
- 主要目标为比较CR、PE和EMDR与WL在基线至6个月随访期间研究者评估的PTSD症状严重度随时间的变化。
- 次要目标包括在中期治疗、治疗后和6个月随访各时间点检验上述效果,以及检验 clinician-rated PTSD诊断存在性和自评(复杂)PTSD症状严重度。
关键数值与推荐
- CAPS-5总分≥23且符合DSM-5 PTSD全部诊断标准。
- SCID-5确认精神分裂症谱系精神病性障碍。
- 年龄≥16岁。
- 干预为16次TFT或WL,均联合精神病常规治疗。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Many people with psychotic disorders experience symptoms of post-traumatic stress disorder (PTSD). In recent years, several trauma-focused therapies (TFTs), including cognitive restructuring (CR), prolonged exposure (PE), and eye movement desensitization and reprocessing (EMDR) have been studied and found to be safe and effective in reducing PTSD symptoms in individuals with psychosis. However, studies were conducted in different countries, with varying inclusion criteria, therapy duration, control groups, and trial outcomes. RE.PROCESS will be the first study to compare the impact of CR, PE, and EMDR with a waiting list control condition within the same context. METHODS AND ANALYSIS: This is the protocol of a pragmatic, single-blind, multicentre, superiority randomized controlled trial, in which CR, PE, and EMDR are compared to a waiting list control condition for TFT (WL) in a naturalistic treatment setting. Inclusion criteria are as follows: age ≥ 16 years; meeting full DSM-5 diagnostic criteria for PTSD on the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), with a total CAPS score ≥ 23; and a psychotic disorder in the schizophrenia spectrum confirmed by the Structured Clinical Interview for DSM-5 (SCID-5). Participants (N=200) will be randomly allocated to 16 sessions of one of the TFTs or WL, in addition to receiving treatment as usual (TAU) for psychosis. The primary objective is to compare the effects of CR, PE, and EMDR to WL on researcher-rated severity of PTSD symptoms over time from baseline to 6-month follow-up. Secondary objectives are to examine these effects at the separate time-points (i.e., mid-treatment, post-treatment, and at 6-month follow-up) and to test the effects for clinician-rated presence of PTSD diagnosis, and self-rated severity of (complex) PTSD symptoms. DISCUSSION: This is the first RCT to directly compare the effects of CR, PE, and EMDR within the same context to TAU on PTSD symptoms in individuals with psychosis and PTSD. Secondary effects on clinical and functional outcomes will be investigated both directly after therapy and long term. TRIAL REGISTRATION: ISRCTN ISRCTN56150327 . Registered 18 June 2019.
引用
- Burger SR, van der Linden T, Hardy A, et al. Trauma-focused therapies for post-traumatic stress in psychosis: study protocol for the RE.PROCESS randomized controlled trial. Trials. 2022. PMID: 36199107. doi:10.1186/s13063-022-06808-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。